Table 1 Clinical and biochemical characteristics of MMCAI patients according to 30-day survival
Survivors (n = 33) | Non-survivors (n = 33) | P value | |
|---|---|---|---|
Age (years) - median (p 25–75) | 59 (47–68) | 64 (54–70) | 0.30 |
Gender female - n (%) | 14 (42.4) | 13 (39.4) | 0.99 |
Arterial hypertension - n (%) | 19 (57.6) | 16 (48.5) | 0.62 |
Diabetes mellitus - n (%) | 4 (12.1) | 9 (27.3) | 0.22 |
Chronic renal failure - n (%) | 2 (6.1) | 2 (6.1) | 0.99 |
COPD - n (%) | 1 (3.0) | 1 (3.0) | 0.99 |
Heart failure - n (%) | 1 (3.0) | 1 (3.0) | 0.99 |
Haemorrhagic transformation - n (%) | 7 (21.2) | 6 (18.2) | 0.99 |
Decompressive craniectomy – n (%) | 9 (27.3) | 6 (18.2) | 0.56 |
Temperature (°C) - median (p 25–75) | 36.4 (35.8–37.0) | 37.0 (36.0–37.4) | 0.19 |
Sodium (mEq/L)- median (p 25–75) | 139 (137–145) | 140 (139–146) | 0.41 |
Platelets - median×103/mm3 (p 25–75) | 214 (170–280) | 170 (131–212) | 0.008 |
PaO2 (mmHg) - median (p 25–75) | 137 (104–207) | 114 (86–153) | 0.26 |
PaO2/FI02 ratio - median (p 25–75) | 300 (197–372) | 248 (184–330) | 0.22 |
Leukocytes-median×103/mm3 (p 25–75) | 12.5 (9.5–17.0) | 13.9 (9.3–21.4) | 0.43 |
Lactic acid (mmol/L)-median (p 25–75) | 1.30 (0.90–1.70) | 1.40 (1.00–2.10) | 0.25 |
INR - median (p 25–75) | 1.09 (1.01–1.20) | 1.20 (1.05–1.31) | 0.10 |
Hemoglobin (g/dL) - median (p 25–75) | 12.2 (11.4–14.4) | 13.7 (11.0–15.0) | 0.78 |
Glycemia (g/dL) - median (p 25–75) | 128 (100–170) | 135 (105–160) | 0.99 |
GCS score - median (p 25–75) | 7 (6–8) | 6 (3–7) | 0.01 |
Fibrinogen (mg/dl) - median (p 25–75) | 440 (335–494) | 419 (311–631) | 0.83 |
Creatinine (mg/dl) - median (p 25–75) | 0.80 (0.60–1.15) | 1.00 (0.76–1.28) | 0.12 |
CCCK-18 (u/L) - median (p 25–75) | 238 (160–290) | 321 (279–351) | < 0.001 |
Bilirubin (mg/dl) - median (p 25–75) | 0.70 (0.40–0.95) | 0.70 (0.33–1.10) | 0.86 |
aPTT (seconds) - median (p 25–75) | 28 (26–30) | 27 (26–32) | 0.77 |
APACHE-II score - median (p 25–75) | 20 (16–25) | 22 (19–27) | 0.09 |